Isolated polyhydramnios in the third trimester or polyhydramnios secondary to late-onset gestational diabetes: is it worth distinguishing?

被引:0
作者
Ozkan, Sadullah [1 ]
Dereli, Murat Levent [1 ]
Sucu, Sadun [1 ]
Varli, Erol Nadi [1 ]
Akay, Arife [1 ]
Uzlu, Safiye Elif [2 ]
Caglar, Ali Turhan [1 ]
Engin-Ustun, Yaprak [1 ]
机构
[1] Etlik Lady Zubeyde Matern & Womens Hlth Teaching &, Dept Obstet & Gynaecol Ankara, Ankara, Turkiye
[2] Etlik Lady Zubeyde Matern & Womens Hlth Teaching &, Dept Neonatol, Ankara, Turkiye
来源
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2024年 / 70卷 / 06期
关键词
Gestational diabetes mellitus; Polyhydramnios; Late-onset; Outcome; Oral glucose tolerance test; HYPERGLYCEMIA; PREGNANCY; DIAGNOSIS;
D O I
10.1590/1806-9282.20231390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: The aim of this study was to compare pregnancy outcomes of patients with polyhydramnios due to late-onset gestational diabetes mellitus and patients with isolated polyhydramnios. METHODS: Of the women who fully participated in prenatal examinations at Etlik Lady Z & uuml;beyde Hospital between January 1, 2018, and December 31, 2019, women with polyhydramnios of nonfetal-placental origin manifesting in the third trimester were retrospectively reviewed. Women with normal 75-g oral glucose tolerance test results between 24 and 28 weeks gestation who met the inclusion criteria were enrolled in the study and divided into two groups based on the results of rescreening with the 75-g oral glucose tolerance test for polyhydramnios in the third trimester: women with isolated polyhydramnios (group 1) and women with late-onset polyhydramnios due to gestational diabetes mellitus (group 2). RESULTS: There were a total of 295 participants, of whom 35 (11.8%) were diagnosed with polyhydramnios due to late-onset gestational diabetes mellitus. There were no differences in the main outcomes. Birthweight and gestational age at birth were identified as independent risk factors for predicting composite maternal outcome {[odds ratio (OR)=1.273, 95% confidence interval (CI) 1.063-1.524, p=0.009]} and composite neonatal outcome (OR=0.606, CI 0.494-0.744, p<0.001), respectively. CONCLUSION: Polyhydramnios in late pregnancy without evidence of pregnancy-related causes leading to polyhydramnios may be a sign of late-onset gestational diabetes mellitus in women with a normal prior oral glucose tolerance test. As pregnancy outcomes and management were indifferent, it does not seem necessary or useful to diagnose whether or not late-onset gestational diabetes mellitus is present.
引用
收藏
页数:6
相关论文
共 16 条
  • [1] Boriboonhirunsarn Dittakarn, 2007, Journal of the Medical Association of Thailand, V90, P1269
  • [2] Regulation of amniotic fluid volume: insights derived from amniotic fluid volume function curves
    Brace, Robert A.
    Cheung, Cecilia Y.
    Anderson, Debra F.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2018, 315 (04) : R777 - R789
  • [3] Screening for late-onset gestational diabetes: Are there any clinical benefits?
    Cauldwell, Matthew
    Chmielewska, Basia
    Kaur, Kiran
    van-de-l'Isle, Yolande
    Sherry, Anneka
    Coote, Ingrid Watt
    Steer, Philip J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (13) : 2176 - 2183
  • [4] Polyhydramnios or Excessive Fetal Growth Are Markers for Abnormal Perinatal Outcome in Euglycemic Pregnancies
    Crimmins, Sarah
    Mo, Cecilia
    Nassar, Yomna
    Kopelman, Jerome N.
    Turan, Ozhan M.
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2018, 35 (02) : 140 - 145
  • [5] Finding the best method for screening for gestational diabetes mellitus: fetal thymic-thoracic ratio or fetal thymus transverse diameter
    Gok, Koray
    Ozden, Selcuk
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (02): : 303 - 307
  • [6] Polyhydramnios: Causes, Diagnosis and Therapy
    Hamza, A.
    Herr, D.
    Solomayer, E. F.
    Meyberg-Solomayer, G.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2013, 73 (12) : 1241 - 1246
  • [7] Hyperglycemia and Adverse Pregnancy Outcomes
    Metzger, Boyd E.
    Coustan, Donald R.
    Trimble, Elisabeth R.
    [J]. CLINICAL CHEMISTRY, 2019, 65 (07) : 937 - 938
  • [8] International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
    Metzger, Boyd E.
    Gabbe, Steven G.
    Persson, Bengt
    Buchanan, Thomas A.
    Catalano, Patrick M.
    Damm, Peter
    Dyer, Alan R.
    de Leiva, Alberto
    Hod, Moshe
    Kitzmiller, John L.
    Lowe, Lynn P.
    McIntyre, H. David
    Oats, Jeremy J. N.
    Omori, Yasue
    Schmidt, Maria Ines
    Balaji, Vijayam
    Callaghan, William M.
    Chen, Rony
    Conway, Deborah
    Corcoy, Rosa
    Coustan, Donald R.
    Dabelea, Dana
    Fagen, Cathy
    Feig, Denice S.
    Ferrara, Assiamira
    Geil, Patti
    Hadden, David R.
    Hillier, Teresa A.
    Hiramatsu, Yuji
    Houde, Ghislaine
    Inturissi, Maribeth
    Jang, Hak C
    Jovanovic, Lois
    Kautsky-Willer, Alexandra
    Kirkman, M. Sue
    Kjos, Siri L.
    Landon, Mark B.
    Lapolla, Annunziata
    Lowe, Julia
    Mathiesen, H. Elisabeth R.
    Mello, Giorgio
    Meltzer, Sara J.
    Moore, Thomas R.
    Nolan, Christopher J.
    Ovesen, Per
    Pettitt, David
    Reader, Diane M.
    Rowan, Janet A.
    Sacks, David A.
    Schaefer-Graf, Ute
    [J]. DIABETES CARE, 2010, 33 (03) : 676 - 682
  • [9] Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia
    Muche, Achenef Asmamaw
    Olayemi, Oladapo O.
    Gete, Yigzaw Kebede
    [J]. BMC PREGNANCY AND CHILDBIRTH, 2020, 20 (01)
  • [10] Parveen N, 2022, IRAN J PUBLIC HEALTH, V51, P1030, DOI 10.18502/ijph.v51i5.9418